Iren [IREN] vs Goldman Sachs [GS] Detailed Stock Comparison
Iren
NASDAQ
Loading...
Goldman Sachs
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Iren wins in 6 metrics, Goldman Sachs wins in 11 metrics, with 0 ties. Goldman Sachs appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Iren | Goldman Sachs | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 3.56 | 16.10 | Iren |
| Price-to-Book Ratio | 2.94 | 1.94 | Goldman Sachs |
| Debt-to-Equity Ratio | 22.73 | 588.39 | Iren |
| PEG Ratio | -0.04 | 0.61 | Iren |
| EV/EBITDA | 39.77 | N/A | N/A |
| Profit Margin (TTM) | -9.44% | 28.40% | Goldman Sachs |
| Operating Margin (TTM) | 18.84% | 35.74% | Goldman Sachs |
| EBITDA Margin (TTM) | 18.84% | 35.74% | Goldman Sachs |
| Return on Equity | -3.39% | 12.74% | Goldman Sachs |
| Return on Assets (TTM) | -0.68% | 0.90% | Goldman Sachs |
| Free Cash Flow (TTM) | $-610.78M | $-15.30B | Iren |
| Dividend Yield | N/A | 1.42% | N/A |
| 1-Year Return | 127.26% | 40.54% | Iren |
| Price-to-Sales Ratio (TTM) | 11.99 | 4.04 | Goldman Sachs |
| Enterprise Value | $5.15B | $-24.30B | Iren |
| EV/Revenue Ratio | 13.62 | -0.44 | Goldman Sachs |
| Gross Profit Margin (TTM) | 94.85% | N/A | N/A |
| Revenue per Share (TTM) | $2 | $171 | Goldman Sachs |
| Earnings per Share (Diluted) | $-0.31 | $45.39 | Goldman Sachs |
| Beta (Stock Volatility) | 3.99 | 1.37 | Goldman Sachs |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Iren vs Goldman Sachs Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Iren | 9.37% | 2.67% | 7.93% | 120.36% | 80.06% | 87.28% |
| Goldman Sachs | 3.60% | -4.18% | 1.41% | 20.64% | 14.44% | 24.52% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Iren | 127.26% | 305.59% | -21.01% | -21.01% | -21.01% | -21.01% |
| Goldman Sachs | 40.54% | 112.83% | 244.69% | 281.33% | 412.31% | 552.35% |
Performance & Financial Health Analysis: Iren vs Goldman Sachs
| Metric | IREN | GS |
|---|---|---|
| Market Information | ||
| Market Cap | $4.53B | $221.28B |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 22,350,126 | 1,585,930 |
| 90 Day Avg. Volume | 25,511,285 | 1,935,293 |
| Last Close | $21.42 | $741.69 |
| 52 Week Range | $5.12 - $21.72 | $439.38 - $749.05 |
| % from 52W High | -1.36% | -0.98% |
| All-Time High | $28.25 (Nov 15, 2021) | $749.05 (Aug 15, 2025) |
| % from All-Time High | -24.18% | -0.98% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 1.73% | 0.14% |
| Quarterly Earnings Growth | 1.81% | 0.22% |
| Financial Health | ||
| Profit Margin (TTM) | -0.09% | 0.28% |
| Operating Margin (TTM) | 0.19% | 0.36% |
| Return on Equity (TTM) | -0.03% | 0.13% |
| Debt to Equity (MRQ) | 22.73 | 588.39 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.38 | $376.89 |
| Cash per Share (MRQ) | $0.76 | $3,402.82 |
| Operating Cash Flow (TTM) | $-210,571,008 | $-22,851,999,744 |
| Levered Free Cash Flow (TTM) | $-990,652,480 | $13.53B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.42% |
| Last 12-Month Dividend | N/A | $9.00 |
Valuation & Enterprise Metrics Analysis: Iren vs Goldman Sachs
| Metric | IREN | GS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 3.56 | 16.10 |
| Forward P/E | 55.09 | 17.59 |
| PEG Ratio | -0.04 | 0.61 |
| Price to Sales (TTM) | 11.99 | 4.04 |
| Price to Book (MRQ) | 2.94 | 1.94 |
| Market Capitalization | ||
| Market Capitalization | $4.53B | $221.28B |
| Enterprise Value | $5.15B | $-24,295,071,744 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 13.62 | -0.44 |
| Enterprise to EBITDA | 39.77 | N/A |
| Risk & Other Metrics | ||
| Beta | 3.99 | 1.37 |
| Book Value per Share (MRQ) | $6.38 | $376.89 |
Financial Statements Comparison: Iren vs Goldman Sachs
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | IREN | GS |
|---|---|---|
| Revenue/Sales | $144.82M | $15.06B |
| Cost of Goods Sold | $7.46M | N/A |
| Gross Profit | $137.36M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $24.62M | N/A |
| EBITDA | $77.27M | N/A |
| Pre-Tax Income | $29.27M | $5.65B |
| Income Tax | $5.04M | $909.00M |
| Net Income (Profit) | $24.23M | $4.74B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | IREN | GS |
|---|---|---|
| Cash & Equivalents | $184.33M | $167.41B |
| Total Current Assets | $255.91M | N/A |
| Total Current Liabilities | $553.11M | N/A |
| Long-Term Debt | $1.23M | $271.73B |
| Total Shareholders Equity | $1.43B | $124.30B |
| Retained Earnings | $-691.84M | $157.02B |
| Property, Plant & Equipment | $948.97M | $24.59B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | IREN | GS |
|---|---|---|
| Operating Cash Flow | N/A | $11.67B |
| Capital Expenditures | $-442.15M | $-354.00M |
| Free Cash Flow | $-491.82M | $-37.73B |
| Debt Repayment | $-126,000 | $-17.14B |
| Common Stock Repurchase | N/A | $-4.36B |
Short Interest & Institutional Ownership Analysis
| Metric | IREN | GS |
|---|---|---|
| Shares Short | 26.86M | 5.98M |
| Short Ratio | 0.85 | 2.65 |
| Short % of Float | 0.12% | 0.02% |
| Average Daily Volume (10 Day) | 22,350,126 | 1,585,930 |
| Average Daily Volume (90 Day) | 25,511,285 | 1,935,293 |
| Shares Outstanding | 186.37M | 310.65M |
| Float Shares | 198.26M | 287.06M |
| % Held by Insiders | 0.06% | 0.01% |
| % Held by Institutions | 0.71% | 0.75% |
Dividend Analysis & Yield Comparison: Iren vs Goldman Sachs
| Metric | IREN | GS |
|---|---|---|
| Last 12-Month Dividend | N/A | $9.00 |
| Last 12-Month Dividend Yield | N/A | 1.42% |
| 3-Year Avg Annual Dividend | N/A | $9.08 |
| 3-Year Avg Dividend Yield | N/A | 0.67% |
| 3-Year Total Dividends | N/A | $27.25 |
| Ex-Dividend Date | N/A | Feb 28, 2025 |